Core Points - Mingyang Technology (920663) closed at 21.71 yuan on October 15, 2025, marking a 5.9% increase from the previous trading day, with a total market capitalization of 2.899 billion yuan [1] - The company announced a cash dividend distribution plan for the first half of 2025, approved by the shareholders' meeting on August 27, 2025 [1] - The dividend distribution is based on a total share capital of 133,552,510 shares, with a payout of 2.246307 yuan per 10 shares, totaling approximately 30 million yuan [1] - The record date for the dividend is October 21, 2025, and the ex-dividend date is October 22, 2025 [1] - Cash dividends will be directly credited to shareholders' accounts by China Securities Depository and Clearing Corporation Limited, Beijing Branch [1] Financial Performance - The stock opened at 20.6 yuan, reached a high of 21.71 yuan, and a low of 20.51 yuan on the trading day [1] - The trading volume for the day was 47.7642 million yuan, with a turnover rate of 3.54% [1] Taxation Details - Individual shareholders and investment funds will be subject to differentiated individual income tax policies based on their holding periods [1] - Qualified foreign investors will have a withholding tax rate of 10%, resulting in an effective payout of 2.021676 yuan per 10 shares [1] - Other institutional investors and corporate shareholders are responsible for their own tax payments [1]

证券代码：837663 证券简称：明阳科技 公告编号：2025-119 明阳科技（苏州）股份有限公司 投资者关系活动记录表 □其他 二、 投资者关系活动情况 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 √特定对象调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 活动时间：2025 年 9 月 23 日 活动地点：公司会议室 参会单位及人员：东方财富证券 上市公司接待人员：董事、副总经理、董事会秘书沈旸，证券事务代表倪超 超 三、 投资者关系活动主要内容 本次投资者关系活动以线下会议方式展开，就投资者关心的问题进行了沟通 与交流。本次投资者关系活动的主要问题及公司对问题的回复情况如下： 问题 1：汽车电动化、智能化趋势对于公司产品市场规模的影响？ 回答：汽车电动化和智能化趋势下，用户对于汽车座椅的功能和舒适性提出 了更高的要求。因此，汽车座椅调节机构的数量增多，且电动调节逐渐代替手动 调节。公司重点开发并推广的调节机构总成件，适用于小桌板、扶 ...

Core Viewpoint - The article emphasizes the emergence of a new paradigm in China's economy, termed the "new new three samples," which includes robotics, artificial intelligence (AI), and innovative pharmaceuticals, as key drivers for high-quality economic development and a shift from traditional growth models to technology-led advancements [1][4][29]. Robotics Sector - The robotics sector has seen significant market capitalization growth, with companies like Huichuan Technology exceeding 200 billion yuan and several stocks doubling in price within the year [2][13]. - The market for industrial robots in China is projected to reach 302,000 units in 2024, maintaining its position as the largest industrial robot market globally [30]. - Key challenges include reliance on imported high-end servo motors and precision components, which need to be addressed to enhance domestic capabilities [33]. Artificial Intelligence Sector - The AI sector is characterized by a large number of high-value companies, with six firms exceeding a market cap of 100 billion yuan, including Cambricon and Hikvision [19]. - The demand for AI capabilities has surged, particularly in large model applications, leading to significant revenue growth for companies like Industrial Fulian and Cambricon, with year-on-year increases of 35.58% and 4347.82%, respectively [20]. - The sector is supported by national policies aimed at integrating AI into various industries, with a comprehensive action plan released to enhance AI's role in economic development [22]. Innovative Pharmaceuticals Sector - The innovative pharmaceuticals sector is represented by major players like Heng Rui Medicine, which is nearing a market cap of 500 billion yuan, and BeiGene, which recently achieved profitability [24][28]. - Recent policy measures have been introduced to support the development of innovative drugs, including streamlined approval processes and enhanced reimbursement mechanisms [27]. - The sector is witnessing a shift from loss-making to profitability, with companies like BeiGene demonstrating the commercial viability of innovative drug models [28]. Strategic Importance - The "new new three samples" signify a transition from scale-driven manufacturing to technology-driven innovation, crucial for enhancing China's global competitiveness and economic resilience [7][9][31]. - The collaboration among robotics, AI, and innovative pharmaceuticals creates a synergistic effect that strengthens overall productivity and fosters new business models [8][31]. - Addressing the "bottleneck" issues in these sectors is essential for sustaining growth and achieving leadership in global technology competition [32][33]. Policy Recommendations - To enhance competitiveness, policies should focus on data openness, regulatory reforms, and infrastructure development to support AI and innovative pharmaceuticals [35][38]. - Establishing a robust talent pipeline and fostering interdisciplinary education will be critical for sustaining innovation in these sectors [37][38]. - Encouraging public-private partnerships and international collaboration will further strengthen China's position in the global market [39].

证券代码：837663 证券简称：明阳科技 公告编号：2025-118 明阳科技（苏州）股份有限公司 回购股份注销完成暨股份变动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、 定向回购股份注销情况 公司通过股份回购专用证券账户，共回购 303,680 股，占回购前公司总股本的比例 为 0.23%。公司已于 2025 年 9 月 10 日在中国证券登记结算有限责任公司北京分公司办 理完毕上述 303,680 股回购股份的注销手续。本次回购股份注销完成前，公司股份总额 为 133,856,190 股，本次回购股份注销完成后，公司股份总额为 133,552,510 股，公司剩 余库存股 0 股。 公司将按照规定办理工商变更登记手续,并申领新的营业执照。 四、 备查文件 | 类别 | 注销前 | | 注销后 | | | --- | --- | --- | --- | --- | | | 数量（股） | 比例（%） | 数量（股） | 比例（%） | | 1.有限售条件股份 | 70,593,353 | ...

东吴证券股份有限公司 关于明阳科技(苏州) 股份有限公司 | 事项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 1、信息披露 | | 不适用 | | 2、公司内部制度的建立和执行 | | 不适用 | | "三会"运作 | | 不适用 | l | 4、控股股东及实际控制人变动 | 元 | 不适用 | | --- | --- | --- | | 5、募集资金存放及使用 | 元 | 不适用 | | 6、关联交易 | 无 | 不适用 | | 7、对外担保 | 无 | 不适用 | | 8、收购、出售资产 | 无 | 不适用 | | 9、其他业务类别重要事项(包括对外投资、 | 元 | 不适用 | | 风险投资、委托理财、财务资助、套期保值等) | | | | 10、发行人或者聘请的中介机构配合保荐工作 | 元 | 不适用 | | 的情况 | | | 三、公司及股东承诺事项履行情况 2025 年半年度持续督导跟踪报告 根据《证券发行上市保荐业务管理办法》《北京证券交易所股票上市规则》 等有关法律法规、规范性文件等的规定,东吴证券股份有限公司(以下简称"东 吴证券"、"保荐机构"）作为明 ...

Group 1 - Huami New Materials surged over 13% [1] - Weike Technology increased by more than 10% [1] - Ningbo Huaxiang and Chaojie Co. both rose over 8% [1] - Shuangyi Technology, Mingyang Technology, and Yokogawa Precision also experienced gains [1]

Core Viewpoint - Mingyang Technology announced the election of Ms. Wang Meihua as the employee representative director during the first employee representative meeting scheduled for August 27, 2025 [2] Company Summary - The company will hold its first employee representative meeting on August 27, 2025 [2] - Ms. Wang Meihua has been elected as the employee representative director [2]

（文章来源：证券日报） 证券日报网讯 8月29日晚间，明阳科技发布公告称，公司于2025年8月27日召开2025年第一次职工代表 大会，审议通过《关于选举王美华为公司第四届董事会职工代表董事的议案》。 ...

明阳科技（苏州）股份有限公司 董事变动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、职工代表董事任命的基本情况 明阳科技（苏州）股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开 2025 年第一次职工代表大会，审议并通过了《关于选举王美华为公司第四届董事会职工代表 董事的议案》。 选举王美华女士为公司职工代表董事，任职期限至第四届董事会届满之日止，自 2025 年 8 月 27 日起生效。该人员持有公司股份 0 股，占公司股本的 0.00%，不是失信 联合惩戒对象。 （上述人员简历详见附件） 二、董事离任的基本情况 证券代码：837663 证券简称：明阳科技 公告编号：2025-116 本公司沈如意先生，因个人原因辞任，自 2025 年 8 月 27 日起不再担任董事。该人 员持有公司股份 303,680 股，占公司股本的 0.23%，不是失信联合惩戒对象，离任后继 续担任副总经理职务，存在未履行完毕的公开承诺。 离任董事沈如意先生于公司向不特定合格投资者公开发行时作出的 ...

2025 年第一次职工代表大会决议公告 证券代码：837663 证券简称：明阳科技 公告编号：2025-115 明阳科技（苏州）股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间：2025 年 8 月 27 日 2、会议召开地点：公司会议室 3、会议召开方式：现场会议 1、议案内容： 根据《公司法》、《明阳科技（苏州）股份有限公司章程》、《北京证券交易 所股票上市规则》、《北京证券交易所上市公司持续监管办法（试行）》等的相关 4、发出职工代表大会会议通知的时间和方式：2025 年 8 月 17 日以书面通 知的方式发出 5、会议主持人：王美华女士 6、召开情况合法、合规、合章程性说明：本次会议的召开符合相关法律、 法规、规范性文件和公司章程的规定。 （二）会议出席情况 会议应出席职工代表 30 人，出席和授权出席职工代表 30 人 二、会议审议情况 （一） 审议通过《关于选举王美华为公司第四届董事会职工代表董事的议 案》 规定，职工 ...